The effects of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for the LDL receptor and HMG CoA reductase in F1B hamsters
- 1 May 1998
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 138 (1) , 43-52
- https://doi.org/10.1016/s0021-9150(97)00302-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Lovastatin inhibits diet induced atherosclerosis in F1B Golden Syrian hamstersAtherosclerosis, 1995
- Sleep disturbance and appetite loss after lovastatinThe Lancet, 1994
- Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)Annals of Internal Medicine, 1993
- Dietary fatty acids regulate hepatic low density lipoprotein (LDL) transport by altering LDL receptor protein and mRNA levels.Journal of Clinical Investigation, 1993
- Plasma lipoproteins in the golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA-I-containing particlesJournal of Lipid Research, 1993
- Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamstersAtherosclerosis, 1991
- Lovastatin is hypertriglyceridemic in Syrian Golden hamstersBiochemical and Biophysical Research Communications, 1988
- The hyperlipidemic hamster as a model of experimental atherosclerosisAtherosclerosis, 1987
- Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractionsClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.Proceedings of the National Academy of Sciences, 1986